Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
about
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryMapping the target localization and biodistribution of non-radiolabeled VMAT2 ligands in rat brain.In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease.Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies.Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.PET radioligands for the vesicular transporters for monoamines and acetylcholine.Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
P2860
Q24601233-D67AC7F6-485A-4E8F-8FD3-B0CF56B078E2Q33574108-CDB0BDBD-8B21-4CE1-AAE4-7FEA1BD68D28Q34018843-F7D5700E-9A3A-4F75-9A76-70157FD7294EQ35524103-83DF4D90-0A7A-4E97-AE4C-9D1D90C10E8DQ36296658-53672DE6-A436-49EA-9DB5-1CAEECCE0572Q36773604-B6714D2C-EA8F-430D-B265-9A1BD7C7F230Q37013071-EF144C47-09F0-4857-BAAB-44758A7A6EF0Q37640085-A20C4C5F-D963-43ED-AA68-7F381FAE3786Q38166971-E9BE4BFA-DC58-40B4-A28F-E8D3C39DF991Q41458043-790C55C5-BB9D-4DF8-A4B8-A5477681AA77Q48496264-4FB55CD8-EB40-4D50-8B83-FE1668D741C2Q53080671-4CAB0734-CD57-4F55-AE22-4276CA50440A
P2860
Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@ast
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@en
type
label
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@ast
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@en
prefLabel
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@ast
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@en
P2093
P2860
P1476
Pharmacokinetics of [(18)F]flu ...... azine in rat and monkey brain.
@en
P2093
Brian Hockley
Catherine Hou
Datta E Ponde
Hank F Kung
Lihsueh Lee
Mei-Ping Kung
Michael R Kilbourn
Rajesh Goswami
P2860
P304
P356
10.1016/J.NUCMEDBIO.2007.01.007
P577
2007-04-01T00:00:00Z